Petrina Kamya
Vice President & Global Head, AI Platforms Insilico Medicine
Seminars
Thursday 19th March 2026
Panel Discussion: Is 2026 the Year for Demonstrating the Practical ROI of AI/ML-Integrated Discovery for Small Molecules?
9:00 am
This industry leaders panel will discuss the small molecule industry collaborations and advancements shaping the space, key challenges to overcome, and where the biggest opportunities remain.
- Taking stock of the strengths, weaknesses, opportunities and threats (SWOT) of AI/ML-derived small molecules
- What advancements in AI/ML x med chem x computational convergence should we be most excited about?
- How do you perceive the AI/ML-derived small molecule space? How has industry sentiment changed in the last 12 months?
- What are the technical or scientific bottlenecks that are slowing AI/ML-derived small molecule discovery?
- What are the most reliable and experimentally validated use cases for AI/ML-methods that are being integrated into the small molecule discovery funnel? And which use cases for small molecule discovery remain challenging to get right?
Thursday 19th March 2026
Harnessing Pharmaceutical Superintelligence & Generative Molecular Design Across the End-to-End Discovery Funnel to Derisk Small Molecule Programs
3:00 pm
